Literature DB >> 16198081

Middle-ear ceruminous adenoma as a rare cause of hearing loss and vertigo: case reports.

Krystyna Orendorz-Fraczkowska1, Marzena Jaworska, Wojciech Gawron, Roman Badowski.   

Abstract

Middle-ear ceruminous adenomas are rare benign neoplasms arising from the epithelium of the middle ear. Progressive hearing loss, ear fullness and tinnitus are common symptoms of this tumour; facial nerve paresis and vestibular disturbances occur very infrequently. We present two cases of middle-ear ceruminous adenomas, one showed rapid unilateral hearing loss with aural fullness, followed by purulent aural discharge and vertigo. In the second case, the disease affected an already deaf ear and the only symptom of the disease was increasing vertigo. The clinical features, intraoperative findings, and histological and radiological findings are presented. The cases are compared to those described in the literature.

Entities:  

Mesh:

Year:  2005        PMID: 16198081     DOI: 10.1016/j.anl.2005.07.002

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  4 in total

1.  Neuro-endocrine adenoma of the middle ear: a case study.

Authors:  D Bakhos; E Lescanne; F Fetissof; A Robier; S Morinière
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-17       Impact factor: 2.503

2.  "Neuroendocrine adenoma of the middle ear with the history of otitis media and carcinoma of the cheek: a case report".

Authors:  Khabti Almuhanna
Journal:  BMC Res Notes       Date:  2014-08-14

3.  Neuroendocrine Adenoma of Middle Ear Causing Acute Onset Facial Palsy- A Rare Case Report.

Authors:  Shakeel-Uz Zaman; Iqra Zakir; Qazi Faraz; Amal-Asif Ahmed; Praneta Kulloo; Shakil Aqil
Journal:  Iran J Otorhinolaryngol       Date:  2019-09

4.  Middle Ear Ceruminous Gland Adenoma Obstructing the Eustachian Tube Orifice.

Authors:  Hamin Jeong; Haemin Noh; Chang-Hee Kim
Journal:  Case Rep Otolaryngol       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.